
Latest from Humphrey
AI Drug Discovery's Real Edge Is the Lab Loop, Not the Model
On 16 June 2026 Merck launched a discovery collaboration with Protillion worth up to $510M in milestones, built on the "lab-in-the-loop" Prot-MaP platform; a day later LG AI Research partnered with D&D Pharmatech on oral peptides for incurable diseases. The differentiator in AI drug discovery is the experimental loop feeding the model — and that loop is also the discipline that makes the promise trustworthy.








